Vasiliki Chounta

2PUBLICATIONS
0CO-AUTHORS
Gene and molecular therapyAboriginal and Torres Strait Islander medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 31, 2021
Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M).

Vasiliki Chounta, Edgar T Overton, Anthony Mills

|May 25, 2020
Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks.

Miranda Murray, Antonio Antela, Anthony Mills

Pageof 1

Frequent Collaborators